Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Braidwell Lp
Form 13F · Q2 2026

Braidwell Lp

CIK 1920938Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.7B
Reported book value
86
Positions
12
Quarters on record
Top 50
Positions

Braidwell Lp — holdings

Top 50 positions of 86, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CAI Caris Life Sciences Inc8.3M+3.1%$147M5.4%
2HNGE Hinge Health Inc1.3M−8.6%$110M4.1%
3GKOS Glaukos Corp591,927−22.5%$83M3.1%
4EWTX Edgewise Therapeutics Inc2.0M−14.9%$81M3.0%
5SYRE Spyre Therapeutics Inc879,467−5.7%$78M2.9%
6IRTC Irhythm Holdings Inc654,262+7.2%$78M2.9%
7NEO Neogenomics Inc4.9M−12.4%$72M2.7%
8KOD Kodiak Sciences Inc1.8M−1.7%$70M2.6%
9XENE Xenon Pharmaceuticals Inc1.1M−15.5%$68M2.5%
10GLUE Monte Rosa Therapeutics Inc2.5M−23.5%$59M2.2%
11DNTH Dianthus Therapeutics Inc594,562−33.9%$58M2.1%
12NBIX Neurocrine Biosciences Inc336,171−48.4%$57M2.1%
13ATEC Alphatec Hldgs Inc6.5M+200.6%$56M2.1%
14GENB Generate Biomedicines Inc3.3M−8.6%$55M2.0%
15MRVI Maravai Lifesciences Hldgs I8.7M−15.0%$54M2.0%
16KRYS Krystal Biotech Inc128,975−29.3%$48M1.8%
17HUM Humana Inc114,500—$45M1.7%
18TMO Thermo Fisher Scientific Inc89,395−3.8%$45M1.7%
19KYMR Kymera Therapeutics Inc378,163+12.0%$43M1.6%
20RYTM Rhythm Pharmaceuticals Inc381,128+22.7%$42M1.6%
21DMRA Damora Therapeutics Inc1.6M+81.1%$42M1.6%
22ACAD Acadia Pharmaceuticals Inc1.6M−33.4%$42M1.5%
23BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc596,753−41.3%$42M1.5%
24TMDX Transmedics Group Inc609,715+85.1%$40M1.5%
25MBX Mbx Biosciences Inc710,880−52.4%$39M1.5%
26CLYM Climb Bio Inc2.8M+82.9%$36M1.3%
27CDNA Caredx Inc1.2M−43.8%$35M1.3%
28MAZE Maze Therapeutics Inc1.1M—$34M1.3%
29DRUG Bright Minds Biosciences Inc483,822−10.4%$34M1.3%
30ACHC Acadia Healthcare Company In1.1M+76.7%$34M1.2%
31NKTR Nektar Therapeutics473,617+112.7%$33M1.2%
32CRVS Corvus Pharmaceuticals Inc2.1M+21.3%$32M1.2%
33NRIX Nurix Therapeutics Inc1.3M−26.5%$31M1.2%
34INSPIRE MED SYS INC Inspire Med Sys Inc677,570+0.0%$30M1.1%
35AVTX Avalo Therapeutics Inc1.6M—$30M1.1%
36ALMR Alamar Biosciences Inc1.1M—$29M1.1%
37DANAHER CORP DEL Danaher Corp Del150,627+8.1%$29M1.1%
38ISRG Intuitive Surgical Inc70,137−9.3%$28M1.0%
39ORKA Oruka Therapeutics Inc278,164—$26M1.0%
40AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc801,395—$26M1.0%
41AVAH Aveanna Healthcare Hldgs Inc3.1M+39.1%$26M1.0%
42BIOA Bioage Labs Inc1.0M−13.9%$25M0.9%
43BSX Boston Scientific Corp587,567+69.6%$25M0.9%
44VERA Vera Therapeutics Inc564,724+7.8%$24M0.9%
45RGEN Repligen Corp177,100+272.8%$24M0.9%
46ZURA Zura Bio Ltd4.0M−0.2%$23M0.9%
47GH Guardant Health Inc147,850−70.4%$22M0.8%
48EOLS Evolus Inc3.2M+1.6%$22M0.8%
49NTRA Natera Inc79,500−38.4%$22M0.8%
50KIDS Orthopediatrics Corp1.1M+0.0%$21M0.8%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.